Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

h_sa_2017a_2017-04-27t11:32:38z0 Hearing Summary

Date: 04/27/2017

Location: LSB A

Final

BILL SUMMARY for SB17-082



HOUSE COMMITTEE ON STATE, VETERANS, & MILITARY AFFAIRS


Votes: View--> Action Taken:
Postpone Senate Bill 17-082 indefinitely. The moti

Refer Senate Bill 17-082 to the Committee of the W
PASS

FAIL







11:33 AM -- SB17-082



Representative Lundeen, bill sponsor, presented Senate Bill 17-082. The reengrossed bill requires the owner or chief executive officer of an addiction program seeking a license to compound, administer, or dispense a controlled substance to have a fingerprint-based criminal history background check conducted by the Colorado Bureau of Investigation (CBI) and the Federal Bureau of Investigation (FBI) when applying for an initial license. The fingerprints and background check request are submitted through the Department of Human Services (DHS) and the fee for the background check must be paid by the applicant to the CBI in the Department of Public Safety. In addition, the bill requires applicants to disclose information to the DHS about any regulatory action taken against the applicant for an addiction program that it operates that is licensed or regulated in another state. The DHS must post information on its website about licensed addiction programs, including their locations, hours of operation, and contact information. The DHS must also report certain information about licensed addiction programs to the Joint Budget Committee and the Health and Human Services committees of the General Assembly by January 1, 2019.



Representative Lundeen answered questions from the committee. Representative Lunden referenced a letter from the Colorado Psychiatric Society in support of the bill (Attachment A).



17HouseState0427AttachA.pdf17HouseState0427AttachA.pdf



11:45 AM --
Lisa Gawenus, Denver Health, testified in opposition to the bill. She provided a handout to the committee (Attachment B). Ms. Gawenus answered questions from the committee.



17HouseState0427AttachB.pdf17HouseState0427AttachB.pdf



12:07 PM --
Angela Bonaguidi, Colorado Organization for the Treatment of Opioid Dependence, testified in opposition to the bill and read a letter from Amanda Malone. Ms. Bonaguidi answered questions from the committee.



12:16 PM --
Tina Beckley, Behavioral Health Group, testified in opposition to the bill.



12:17 PM --
Michele Ryan, Behavioral Health Group, testified in opposition to the bill.





12:19 PM



Ms. Beckley and Ms. Ryan answered questions from the committee.



12:24 PM --
Frank Cornelia, Colorado Behavioral Healthcare Council, testified in opposition to the bill. Mr. Cornelia answered questions from the committee.



12:30 PM --
Cristen Bates, Department of Human Services, testified in a neutral capacity. Ms. Bates answered questions from the committee.





12:37 PM



Representative Lundeen and Ms. Bates answered questions from the committee.





12:40 PM



Representative Lundeen made concluding remarks to the committee. Committee members made comments about the bill.

BILL: SB17-082
TIME: 12:51:10 PM
MOVED: Williams D.
MOTION: Refer Senate Bill 17-082 to the Committee of the Whole. The motion failed on a vote of 3-6.
SECONDED: Leonard
VOTE
Benavidez
No
Hooton
No
Humphrey
Yes
Leonard
Yes
Melton
No
Weissman
No
Williams D.
Yes
Lontine
No
Foote
No
YES: 3 NO: 6 EXC: 0 ABS: 0 FINAL ACTION: FAIL




BILL: SB17-082
TIME: 12:52:06 PM
MOVED: Melton
MOTION: Postpone Senate Bill 17-082 indefinitely. The motion passed on a vote of 6-3.
SECONDED: Lontine
VOTE
Benavidez
Yes
Hooton
Yes
Humphrey
No
Leonard
No
Melton
Yes
Weissman
Yes
Williams D.
No
Lontine
Yes
Foote
Yes
Final YES: 6 NO: 3 EXC: 0 ABS: 0 FINAL ACTION: PASS














Colorado legislature email addresses ending in @state.co.us are no longer active. Please replace @state.co.us with @coleg.gov for Colorado legislature email addresses. Details

The effective date for bills enacted without a safety clause is August 7, 2024, if the General Assembly adjourns sine die on May 8, 2024, unless otherwise specified. Details